review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1567-5769(01)00174-6 |
P698 | PubMed publication ID | 11811926 |
P50 | author | Carrie A Redlich | Q92167446 |
Meryl H Karol | Q122973473 | ||
P2860 | cites work | Uptake and distribution of 14C during and following inhalation exposure to radioactive toluene diisocyanate | Q23909472 |
Autoradiographic Analyses of Guinea Pig Airway Tissues Following Inhalation Exposure to 14C-Labeled Methyl Isocyanate | Q23909832 | ||
Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers | Q23910898 | ||
Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate | Q23912396 | ||
Comparison of sampling methods for monomer and polyisocyanates of 1,6-hexamethylene diisocyanate during spray finishing operations | Q23912527 | ||
Indirect assessment of 4,4'-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin | Q24169498 | ||
Clinical evaluation, management, and prevention of work-related asthma | Q24169547 | ||
Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology | Q71745766 | ||
Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge | Q72269121 | ||
Inhibition of cholinesterase activity by isocyanates | Q72927956 | ||
Urinary hexane diamine as an indicator of occupational exposure to hexamethylene diisocyanate | Q73032471 | ||
Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results | Q73076836 | ||
Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene | Q73091950 | ||
T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma | Q73092925 | ||
Formation, solvolysis, and transcarbamoylation reactions of bis(S-glutathionyl) adducts of 2,4- and 2,6-diisocyanatotoluene | Q73257230 | ||
What is the respiratory retention of inhaled hexamethylene di-isocyanate? | Q73269342 | ||
Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo | Q73286386 | ||
Characterization of airway inflammation after repeated exposures to occupational agents | Q73288268 | ||
Occupational asthma | Q73368880 | ||
Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate | Q73557519 | ||
No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma | Q73777760 | ||
Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI) | Q74009503 | ||
Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma | Q77178460 | ||
Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: relevance of the length of the interval from cessation of exposure | Q77194141 | ||
Immunologic aspects of isocyanate asthma: IL-1 beta, IL-3, IL-4, sIL2R, and sICAM-1 | Q77510263 | ||
Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study | Q77929421 | ||
Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells | Q78121112 | ||
Development of immunoassays for biomonitoring of hexamethylene diisocyanate exposure | Q24813482 | ||
Isocyanate exposure and occupational asthma: a case-referent study | Q28344920 | ||
Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate | Q30658335 | ||
Current diagnostic methods for diisocyanate induced occupational asthma | Q33724281 | ||
Mechanisms of occupational asthma | Q33808131 | ||
Outcome determinants for isocyanate induced occupational asthma among compensation claimants | Q33821036 | ||
Occupational airway sensitizers: an overview on the respective literature | Q33967702 | ||
Cell and molecular biology of chemical allergy | Q34480392 | ||
Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma | Q34655412 | ||
Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians | Q34719886 | ||
Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analyses | Q35490307 | ||
Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns | Q35979356 | ||
Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges | Q36528786 | ||
Bronchial hyperresponsiveness, airway inflammation and occupational asthma induced by toluene diisocyanate | Q37179057 | ||
Exposures to 1,6-hexamethylene diisocyanate during polyurethane spray painting in the U.S. Air Force | Q38495697 | ||
Mechanisms and pathology of occupational asthma | Q40662558 | ||
Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates | Q40685196 | ||
Overview of diisocyanate occupational asthma | Q41035593 | ||
The role of the skin in the development of chemical respiratory hypersensitivity | Q41035765 | ||
Occupational lung disease. 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work | Q41104409 | ||
Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate | Q41850805 | ||
Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates? | Q41882358 | ||
Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma | Q43505946 | ||
4-Hydroxy-2-nonenal increases gamma-glutamylcysteine synthetase gene expression in alveolar epithelial cells | Q43578028 | ||
Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures | Q43679619 | ||
Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure | Q43686372 | ||
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. | Q44293361 | ||
Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs | Q46189525 | ||
Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical | Q46532252 | ||
Is the clinical history a satisfactory means of diagnosing occupational asthma? | Q46751341 | ||
Respiratory sensitization to diphenyl-methane-4,4'-diisocyanate (MDI) in guinea pigs: impact of particle size on induction and elicitation of response | Q47236143 | ||
Occupational asthma, IgE and IgG. | Q47793642 | ||
Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures | Q49307939 | ||
Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. | Q52905120 | ||
HLA class II alleles in isocyanate-induced asthma. | Q54219431 | ||
Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma | Q58192613 | ||
Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure | Q58192653 | ||
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma | Q58877324 | ||
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 | Q58877366 | ||
CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate | Q61522812 | ||
Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents | Q70119864 | ||
Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI) | Q70555837 | ||
Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma | Q70660889 | ||
Immunologic responses to isocyanates in sensitized asthmatic subjects | Q70993319 | ||
Outcome of specific bronchial responsiveness to occupational agents after removal from exposure | Q71395458 | ||
P433 | issue | 2-3 | |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 213-224 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | International Immunopharmacology | Q15751306 |
P1476 | title | Diisocyanate asthma: clinical aspects and immunopathogenesis | |
P478 | volume | 2 |
Q23912077 | A laboratory investigation of the effectiveness of various skin and surface decontaminants for aliphatic polyisocyanates |
Q23909919 | A murine monoclonal antibody with broad specificity for occupationally relevant diisocyanates |
Q37198071 | A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma |
Q34739661 | A survey of airborne and skin exposures to chemicals in footwear and equipment factories in Thailand. |
Q77790140 | Acute 4,4'-methylene diphenyl diisocyanate exposure-mediated downregulation of miR-206-3p and miR-381-3p activates inducible nitric oxide synthase transcription by targeting calcineurin/NFAT signaling in macrophages |
Q89892380 | Analysis of Lung Gene Expression Reveals a Role for Cl- channels in Diisocyanate Induced Airway Eosinophilia in a Mouse Model of Asthma Pathology |
Q25930297 | Animal models of occupational asthma: tools for understanding disease pathogenesis |
Q28388975 | Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate |
Q36317810 | Biomonitoring Hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-specific IgG. |
Q23918567 | Characterization and comparative analysis of 2,4-toluene diisocyanate and 1,6-hexamethylene diisocyanate haptenated human serum albumin and hemoglobin |
Q23918566 | Characterization of methylene diphenyl diisocyanate-haptenated human serum albumin and hemoglobin |
Q77790237 | Circulating miRs-183-5p, -206-3p and -381-3p may serve as novel biomarkers for 4,4'-methylene diphenyl diisocyanate exposure |
Q38468194 | Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters |
Q39417617 | Determination of a new biomarker in subjects exposed to 4,4'-methylenediphenyl diisocyanate |
Q39417598 | Determination of albumin adducts of 4,4'-methylenediphenyl diisocyanate in workers of a 4,4'-methylenedianiline factory |
Q39417625 | Determination of isocyanate biomarkers in construction site workers |
Q39417607 | Determination of isocyanate specific albumin-adducts in workers exposed to toluene diisocyanates |
Q77793527 | Dilysine-methylene diphenyl diisocyanate (MDI), a urine biomarker of MDI exposure? |
Q87614747 | Effect of Ipomea carnea Jacq. flowers on hematological changes in toluene diisocyanate-induced inflammation in Wistar rats |
Q45208294 | Effect of inhaled toluene diisocyanate on local immune response based on murine model for occupational asthma |
Q38889281 | Effects of MBL2 polymorphisms in patients with diisocyanate-induced occupational asthma. |
Q28392720 | Environmental isocyanate-induced asthma: morphologic and pathogenetic aspects of an increasing occupational disease |
Q23921574 | Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitization |
Q23910399 | Genetic variability in susceptibility to occupational respiratory sensitization |
Q23910397 | Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced asthma |
Q23910396 | Genome-wide association study identifies novel loci associated with diisocyanate-induced occupational asthma |
Q40443684 | Glutathione protects human airway proteins and epithelial cells from isocyanates |
Q23909574 | Glutathione reaction products with a chemical allergen, methylene-diphenyl diisocyanate, stimulate alternative macrophage activation and eosinophilic airway inflammation |
Q23909572 | Hexamethylene diisocyanate (HDI) vapor reactivity with glutathione and subsequent transfer to human albumin |
Q45268014 | Host factors in occupational diisocyanate asthma: a Swiss longitudinal study |
Q28393255 | In vitro cleavage of diisocyanate-glutathione conjugates by human gamma-glutamyl transpeptidase-1 |
Q50099206 | Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry |
Q23923273 | Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice |
Q36900965 | Issues in diisocyanate antibody testing |
Q45074610 | Medical Monitoring for Occupational Asthma Among Toluene Diisocyanate Production Workers in the United States |
Q34924987 | Mouse models of diisocyanate asthma |
Q23912076 | Polyisocyanates in occupational environments: a critical review of exposure limits and metrics |
Q24169946 | Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma |
Q23922864 | Production, characterization and utility of a panel of monoclonal antibodies 2 for the detection of toluene diisocyanate haptenated proteins |
Q57010044 | Proteome changes in auricular lymph nodes and serum after dermal sensitization to toluene diisocyanate in mice |
Q51010772 | Reaction products of hexamethylene diisocyanate vapors with "self" molecules in the airways of rabbits exposed via tracheostomy. |
Q35128836 | Recent developments in airway and nose occupational sensitizers |
Q58192427 | Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma |
Q56637870 | Renewable polyamides and polyurethanes derived from limonene |
Q28391755 | Residual Isocyanates in Medical Devices and Products: A Qualitative and Quantitative Assessment |
Q41996947 | Sensitization and cross-reactivity patterns of contact allergy to diisocyanates and corresponding amines: investigation of diphenylmethane-4,4'-diisocyanate, diphenylmethane-4,4'-diamine, dicyclohexylmethane-4,4'-diisocyanate, and dicylohexylmethane |
Q23911463 | Surveillance for isocyanate asthma: a model based cost effectiveness analysis |
Q45948591 | Tissue transglutaminase can be involved in airway inflammation of toluene diisocyanate-induced occupational asthma. |
Q23909608 | Toluene diisocyanate (TDI) disposition and co-localization of immune cells in hair follicles |
Search more.